Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 103 | 2 | 112 | +11 |
| Shares | 35.3M | 3.62M | 36.7M | +4.99M (+15.7%) |
| Value | $116.9M | $12.0M | $196.4M | +$91.4M (+87.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 3,734,408 | $20.1M | 0.00% |
| Ardsley Advisory Partners LP | 500,000 | $2.69M | 0.51% |
| ADAR1 Capital Management, LLC | 302,212 | $1.63M | 0.27% |
| EAM Investors, LLC | 92,522 | $498.7K | 0.07% |
| PDT Partners, LLC | 31,402 | $169.3K | 0.01% |
| Fox Run Management, L.L.C. | 19,002 | $102.4K | 0.02% |
| Intech Investment Management LLC | 14,628 | $78.8K | 0.00% |
| Ameriprise Financial Inc | 12,580 | $67.8K | 0.00% |
| Paloma Partners Management Co | 11,546 | $62.2K | 0.00% |
| Trexquant Investment LP | 11,500 | $62.0K | 0.00% |
| Russell Investments Group, Ltd. | 7,218 | $38.9K | 0.00% |
| US Bancorp | 5,578 | $30.1K | 0.00% |
| Public Employees Retirement System of Ohio | 3,500 | $18.9K | 0.00% |
| Catalyst Funds Management Pty Ltd | 600 | $3.23K | 0.00% |
| Truvestments Capital LLC | 265 | $1.43K | 0.00% |
| Sterling Capital Management LLC | 147 | $792 | 0.00% |
| Wolff Wiese Magana LLC | 113 | $610 | 0.00% |
| GAMMA Investing LLC | 25 | $135 | 0.00% |
| Capital Performance Advisors LLP | 17 | $92 | 0.00% |
Sold out (8)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Johnson & Johnson | 299,669 | $991.9K |
| Millennium Management LLC | 43,825 | $145.1K |
| AQR Capital Management LLC | 34,781 | $115.1K |
| Simplex Trading, LLC | 29,302 | $96.0K |
| Gsa Capital Partners LLP | 16,020 | $53.0K |
| Walleye Capital LLC | 14,168 | $46.9K |
| nVerses Capital, LLC | 1,700 | $5.63K |
| Innealta Capital, LLC | 46 | $152 |
Not filed for Q3 2024 yet (2)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,621,949 | $12.0M |
| Institutional & Family Asset Management, LLC | 50 | $166 |